Saturday, November 23, 2024
Lawyers Run The WorldTrump's FDA Goes After Marijuana CBD Oil Distributors

Trump’s FDA Goes After Marijuana CBD Oil Distributors

-

- Advertisment -spot_img

The U.S. Food and Drug Administration is issuing warning letters to four manufacturers of products containing marijuana component cannabidiol (CBD).

The companies are, in the FDA’s view, “illegally selling products online that claim to prevent, diagnose, treat or cure cancer without evidence to support these outcomes.”

The move, announced Wednesday, comes less than a month after FDA Commissioner Scott Gottlieb said in a Congressional hearing that the agency would soon begin to proactively examine health claims that marijuana providers are making about their products.

“Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors,” Gottlieb said in a press release about the new letters. “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”

Medical marijuana is legal in 29 states, as well as in Guam and Puerto Rico. Studies have shown that it can have some benefits in reducing anxiety, counteracting some types of nausea, and that it may relieve some symptoms of glaucoma and multiple sclerosis.

A cannabis derivative called cannabidiol or CBD for short has been shown to help kids with a severe form of epilepsy called Dravet syndrome and perhaps it can help treat Parkinson’s disease.

The companies targeted by FDA are Stanley Brothers Social Enterprises LLC, Greenroads Health, Natural Alchemist and That’s Natural! Marketing and Consulting.

“We recognize that there’s interest in developing therapies from marijuana and its components, but the safest way for this to occur is through the drug approval process – not through unsubstantiated claims made on a website,” Gottlieb said. “We support sound, scientifically-based research using components derived from marijuana, and we’ll continue to work with product developers who are interested in bringing safe, effective, and quality products to market.”

Pesach Lattin
Pesach Lattinhttp://www.adotat.com
Pesach "Pace" Lattin is one of the top experts in interactive advertising, affiliate marketing. Pesach Lattin is known for his dedication to ethics in marketing, and focus on compliance and fraud in the industry, and has written numerous articles for publications from MediaPost, ClickZ, ADOTAS and his own blogs.

What's your opinion?

Latest news

Disney Gets Dirty: Playing in Programmatic’s Muddy Waters

Once upon a time, Disney stood as the epitome of wholesome family entertainment. But now, the House of Mouse...

The Trade Desk’s Ventura: Shaking Up CTV or Just Stirring the Pot?

Connected TV (CTV) just got a wake-up call—or maybe a Molotov cocktail. The Trade Desk has announced Ventura, its new...

From Big Ideas to Tiny Banners: How #Adtech Shrinks the Dream

When I resurrected this newsletter from the ashes of my previous endeavor—dusted it off like some overambitious Frankenstein experiment—I...

The Ad Tech Racket: How The Trade Desk is Taxing Your Campaigns Into Oblivion

Let’s talk about The Trade Desk (TTD) and their latest contribution to the world of advertising—what can only be...

PubMatic Bets Big on Elon’s X: Bold Innovation or PR Suicide?

PubMatic has officially stepped into the lion’s den, announcing its partnership with Elon Musk’s X (formerly Twitter) as its...

The AdTech Wizard of Odds: Gareth Holmes on Streaming Ads, Helicopters, and Unleashing Sweden’s Secret Sauce 

Adtech is often described as a wild west, but Gareth Holmes makes it sound more like Cirque du Soleil—complete...

Must read

The Trade Desk’s Ventura: Shaking Up CTV or Just Stirring the Pot?

Connected TV (CTV) just got a wake-up call—or maybe...

From Big Ideas to Tiny Banners: How #Adtech Shrinks the Dream

When I resurrected this newsletter from the ashes of...

You might also likeRELATED
Recommended to you